Course Directors: David J. Hass, MD, FACG, and Millie D. Long, MD, MPH, FACG
Attend this year’s Annual Postgraduate Course, “Practical Pearls for the Clinical Gastroenterologist – A Case-Based Approach” and gain practical takeaway points that you can implement in practice. Learn better ways to integrate the newest tools in diagnosis with the latest therapeutic/treatment alternatives to achieve optimal outcomes, improve your awareness and ability to incorporate patient care decision-making issues relating to common and not-so-common GI patient conditions, and enhance your overall capacity to frame effective disease management strategies in your practice.Register for any two courses and save up to 10%!
Can’t join us in-person in Las Vegas?
Maximize your learning with one of our VIRTUAL All-Access Pass options and save 20%!
ACG All-Access Pass: The ACG All-Access Pass includes virtual-only access to the GI Pathophysiology Course, GI Pharmacology Course, Practice Management Summit, Postgraduate Course + Bonus Sessions (formerly Learning Luncheons), and the Annual Scientific Meeting + Bonus Sessions (formerly Breakfast Sessions). Registrants will also receive online access to the 2021 Self-Assessment Test.
NEW for 2021: ACG All-Access Pass + ASGE Endoscopy Course: The ACG All-Access Pass includes virtual-only access to all of the courses in the ACG All-Access Pass PLUS the ASGE Endoscopy Course.
Separate Purchase Required - Must be registered for the Postgraduate Course to purchase access to these sessions.
(Formerly Learning Luncheons)
Peri-Procedural Anticoagulation: WWND (What Would Neena Do)?
Neena S. Abraham, MD, MSc (Epid), FACG
Describe an evidence-based approach for management of peri-procedural anticoagulation – from routine outpatient procedures to therapeutic interventions for GI bleeding.
|Perianal Crohn’s Disease – Evolutions in Management
Miguel D. Regueiro, MD, FACG
Review the latest management of perianal Crohn’s disease, including novel therapeutics, combined medical and surgical approaches and optimization of therapies.
|CAM and Psychological Therapies for Functional and Inflammatory Bowel Disease
Jill K. Deutsch, MD, and Laurie A. Keefer, PhD
Apply current evidence-based strategies for functional bowel disease including both pharmacologic and mind-based therapies such as cognitive behavioral therapies and hypnotherapy.
|Hereditary Pancreatic Cancers – Who Should We Screen and How?
Yasmin G. Hernandez-Barco, MD
Review the role of genetic screening and screening with imaging for pancreatic cancer with a review of the relevant genes and imaging modalities to consider.
|Management of Disorders of the J-Pouch: A Practical Guide
Laura E. Raffals, MD, MS, FACG
Review approaches to the endoscopic assessment of the J-pouch, common disorders of the pouch, and medical management.
|Nutrition 101 for the Gastroenterologist: A Case-Based Approach
John K. DiBaise, MD, FACG
Improve recognition of nutrient deficiencies, review modalities of nutrition support, recognize the warning signs of eating disorders, and review optimal dietary interventions for GI disorders.
|Vascular Diseases of the GI Tract
Paul Feuerstadt, MD, FACG
Discuss the common presentations of the vascular diseases of the GI tract, including colonic ischemia, and acute and chronic mesenteric ischemia.
|PPI Risks – What Should We Be Telling Our Patients in 2021?
Paul Moayyedi, MB ChB, PhD, MPH, FACG
Review the risks, benefits, and discussions to be held with patients to maximize efficacy and minimize risk of PPI medications.
|Hereditary Colorectal Cancer Syndromes: Strategies for Monitoring and Prevention
Carol A. Burke, MD, FACG
Review various hereditary colon cancer syndromes, including a practical algorithm for screening and surveillance.
|Diverticular Disease in 2021: Where Are We Now?
Lisa L. Strate MD, MPH, FACG
Review epidemiology and burden of diverticular disease, optimize management of diverticular complications, and describe treatment strategies for SUDD (symptomatic uncomplicated diverticular disease) and SCAD (segmental colitis associated with diverticula).
|Viral Hepatitis From A-Z
Paul Y. Kwo, MD, FACG
Review the natural history, diagnosis, and evidence-based management for common and rare etiologies of viral hepatitis.
|Fecal Incontinence – Strategies for 2021
Satish S. C. Rao, MD, PhD, FACG
Review the epidemiology and diagnostic approach for fecal incontinence, describe state-of-the-art management in 2021, and future novel/emerging therapies.
|Gastric Intestinal Metaplasia and Gastric Polyps – Optimal Resection and Surveillance Strategies
Douglas R. Morgan, MD, MPH, FACG
Provide an evidence-based workflow to determine how to monitor gastric intestinal metaplasia, fundic polyps, and hyperplastic polyps.
|SIBO – Optimal Strategies for Testing and Treatment
William D. Chey, MD, FACG
Review the best testing and treatment strategies for SIBO, as well as differentiating methane versus hydrogen-predominant pathology.
|Autoimmune Hepatitis and Cholangiopathies: Decoding Overlap Syndromes
Marlyn J. Mayo, MD, FACG
Discuss the epidemiology, diagnosis, and management of autoimmune hepatitis, cholangiopathies, and overlap syndromes, including indications for when to start and stop therapy.
|ID for the GI – GI Presentations of Unusual Infections (Parasitic, Rickettsial, and Atypical Bacterial Infections)
Mark S. Riddle, MD, DrPH
Review the unusual presentations and manifestations of some rarer causes of gastrointestinal infection.
|Digital Health in Gastroenterology: A New Frontier
Brennan M. Spiegel, MD, MSHS, FACG
Discuss the role of digital health in gastroenterology, and the implications for research and clinical practice.
|Endoscopic Ultrasound 101– The Basics and the Emerging Role of LAMS for Complex Anatomy and Pancreatobiliary Disorders
Seth A. Gross, MD, FACG
Review the modality of EUS and the use of luminal apposing metal stents for GI pathology, including LAMS-assisted endoscopic drainage, and when to refer to an interventional gastroenterologist versus referral to a surgeon.
|Interpretation of Esophageal pH Impedance, Manometry: A Case-Based Approach
Felice Schnoll-Sussman, MD, FACG
Apply a practical approach to interpretation of esophageal pH-impedance and manometry studies.
|Cannabis for Gastrointestinal Disorders: Everything You Wanted to Know, But Were Afraid to Ask
Linda Anh B. Nguyen, MD
Provide an overview of the endocannabinoid system and identify the role of cannabinoids in the treatment of functional and inflammatory bowel disease.
|Geriatrics and Gastrointestinal Disorders: Is Age Only a Number?
Bharati Kochar, MD, MSCR
Explain the impact of aging on various GI disorders, discuss the concepts of frailty and polypharmacy, and provide an algorithmic approach to optimally manage geriatric patients with GI disorders.
|Extraintestinal Manifestations in IBD: Beyond the Bowel
Anne G. Tuskey, MD, FACG
Review epidemiology and management of EIMs, including paradoxical manifestations and hidradenitis suppurativa.
|Benign Liver Masses – How to Image, When to Resect: Maximal Yield and Minimal Patient Inconvenience
Joseph Ahn, MD, MS, MBA, FACG
Review the differential of benign liver masses, appropriate imaging protocols for diagnosis, and describe indications (if ever) for biopsy and/or resection.
|Challenging IBD Cases – A Discussion With the Experts from IBD Circle
Samir A. Shah, MD, FACG, and Jean-Paul Achkar, MD, FACG
Apply evidence-based clinical decision-making approaches to various challenging IBD cases encountered by the practicing gastroenterologist.